Vascular endothelial cadherin dysfunction: A predictor of hypertensive nonlobar intracerebral hemorrhage
- PMID: 40656463
- PMCID: PMC12255211
- DOI: 10.25259/SNI_20_2025
Vascular endothelial cadherin dysfunction: A predictor of hypertensive nonlobar intracerebral hemorrhage
Abstract
Background: Endothelial dysfunction plays a key role in intracerebral hemorrhage (ICH), with vascular endothelial cadherin (VE-cadherin) being essential for maintaining blood vessel integrity and the blood-brain barrier. Hypertension increases ICH risk by damaging blood vessel integrity due to inflammatory cascades. Lower VE-cadherin levels in hypertensive patients suggest its potential as an early predictor of ICH risk.
Methods: This 12-month study included 40 hypertensive control patients and 40 hypertensive patients with nonlobar ICH. Blood samples were analyzed using enzyme-linked immunosorbent assays to measure VEcadherin, interferon gamma, and interleukin-17 levels. Receiver operating characteristic analysis determined a VE-cadherin cutoff value, and a regression model assessed its association with ICH risk.
Results: A VE-cadherin cutoff value of 400.8 pg/dL was identified, with higher levels independently linked to lower odds of nonlobar ICH. VE-cadherin was the only biomarker that remained statistically significant in the regression model. These findings suggest that reduced VE-cadherin levels contribute to ICH development, and its measurement may help identify high-risk patients for early intervention.
Conclusion: VE-cadherin dysfunction in hypertension may serve as a predictor of nonlobar ICH risk. Its protective role highlights its potential as a biomarker for risk assessment and prevention strategies in hypertensive patients. These findings may pave the way for targeted interventions in hypertensive populations, warranting further research to confirm its clinical utility.
Keywords: Adherens junction; Gap junction; Hypertension; Intracerebral hemorrhage; Stroke; Vascular endothelial-cadherin.
Copyright: © 2025 Surgical Neurology International.
Conflict of interest statement
There are no conflicts of interest.
Figures


Similar articles
-
Antithrombotic treatment after stroke due to intracerebral haemorrhage.Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD012144. doi: 10.1002/14651858.CD012144.pub3. Cochrane Database Syst Rev. 2023. PMID: 36700520 Free PMC article.
-
Association of Antithrombotic Drug Use With Incident Intracerebral Hemorrhage Location.Neurology. 2024 Jun 25;102(12):e209442. doi: 10.1212/WNL.0000000000209442. Epub 2024 May 21. Neurology. 2024. PMID: 38771998 Free PMC article.
-
Association between red blood cell distribution width-to-albumin ratio and all-cause mortality in intracerebral hemorrhage.Front Nutr. 2025 Jun 4;12:1599104. doi: 10.3389/fnut.2025.1599104. eCollection 2025. Front Nutr. 2025. PMID: 40535050 Free PMC article.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
miR-210 Regulates Autophagy Through the AMPK/mTOR Signaling Pathway, Reduces Neuronal Cell Death and Inflammatory Responses, and Enhances Functional Recovery Following Cerebral Hemorrhage in Mice.Neurochem Res. 2025 Jun 5;50(3):180. doi: 10.1007/s11064-025-04434-7. Neurochem Res. 2025. PMID: 40471451 Free PMC article.
References
-
- Cong X, Kong W. Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease. Cell Signal. 2020;66:109485. - PubMed
-
- Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev Cell. 2009;16:209–21. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous